Work

Investigating the Molecular and Physiological Roles of Glucagon like peptide-1, Scavenger receptor class B type 1 and the Gut Microbiota in Modulating Intestinal Chylomicron Production

Year: 2024
Type: dissertation
Abstract: Major complications associated with type 2 diabetes (T2D) and insulin resistance involve the emergence of proatherogenic particles, primarily due to the intestinal overproduction of apoB48- containing chylomicrons which are further catabolized into proatherogenic remnants and elevating the risk of atherosclerotic cardiovascular disease. Both human and rodent studies have shown that the use of GLP-1R agonists leads to a reduction in chylomicron production. Furthermore, recent findings indicated that the gut microbiota and their metabolites play a significant role in the onset of diabetic dyslipidemia. Considering the principles of precision medicine and the pursuit of translational research aimed at understanding human diseases, we generated novel GLP-1R knockout (KO) and SR-B1 heterozygous (Het) hamster models using CRISPR-CAS9 gene editing technology. In this thesis, I demonstrate a novel role of the microbiota in regulating intestinal chylomicron production. I also explored the underlying molecular mechanisms and investigated the previously understudied direct crosstalk between gut microbiota and SR-B1 in mediatingchylomicron clearance. Antibiotic-induced gut microbiota depletion led to a significant decrease ii in postprandial lipids, apoB48 protein levels, and an increase in plasma GLP-1 levels. 16S rRNA sequencing demonstrated notable changes in the composition of the microbiota within the treatment group. Additionally, bulk RNA sequencing revealed significant alterations in the expression of intestinal transcripts and pathways related to chylomicron production following microbiota depletion in hamsters. Using SR-B1 Het hamsters, I discovered that jejunal SR-B1 plays a key role in mediating the microbiota’s regulatory effect on chylomicron secretion. Subsequently, I characterized the GLP-1R KO hamster under both normal and insulin-resistant conditions. The deletion of the GLP-1R gene in hamsters led to significant changes in the composition of gut microbiota. Notably, depletion of microbiota resulted in a fatal outcome only in GLP-1R KO, with a mortality rate of 54%. Dysbiosis exacerbated the intestinal pathology, with no observed alterations in intestinal immunity in the KO model. These effects were also associated with alterations in both plasma and fecal bile acid profiles in GLP-1R KO model. Altogether, the results obtained from these studies provide support for the effectiveness of targeting the gut microbiota, SR-B1 and GLP-1R as potential therapeutic approaches to modulate intestinal chylomicron production.
Language: English
Open Access status: green
OpenAlex ID: W7225762689
Cites: 558
Cited by:
Related to: 10